C. Kearon, E. A. Akl, A. J. Comerota et al., “Antithrom-botic Therapy for Vte Disease. Antithrombotic Therapy and Prevention of Thrombosis, 9th Edition, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, Vol. 141, Suppl. 2, 2012, pp. e419S-e494S.

has been cited by the following article:

• TITLE: Late Thrombolysis in Massive Pulmonary Thromboembolism

  AUTHORS: Rodrigo Molina Mendoza, Daniel Arnal, Santiago García-del-Valle

  KEYWORDS: Pulmonary Thromboembolism; Thrombolysis; Pulmonary Hypertension

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.2 No.5, November 28, 2012

  ABSTRACT: Pulmonary thromboembolism (PTE) remains a diagnostic and therapeutic challenge for physicians. Anticoagulation with heparin remains as the cornerstone in its management, reserving thrombolysis for cases with hemodynamic impairment. The later has been associated with haemorrhagic complications and has proved beneficial when initiated within the first 48 hours of PTE; but there is little evidence supporting its use passed this time. We present a case of an 84 year old female admitted in our unit and treated successfully with thrombolysis for massive PTE at the fifth day of diagnosis. The patient improved towards complete recovery and was discharged from the hospital 22 days after admission without complications.